04232024Tue
Last updateWed, 27 Mar 2024 6am

Activating transcription factor 3, an early cellular adaptive responder in ischemia/reperfusion‑induced injury

Heng Lina, Ching‑Feng Chengb,c*

aDepartment of Physiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, bDepartment of Pediatrics, Hualien Tzu Chi Hospital,
Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, cSchool of Medicine, Tzu Chi University, Hualien, Taiwan

 

Download PDF

Open Access funded by Buddhist Compassion Relief Tzu Chi Foundation

 

Abstract


Recent studies have reported that ischemia/reperfusion (I/R) may act in the immune system where an exaggerated inflammatory response is initiated. With the activation of the immune system, damage‑associated molecular patterns migrate and adhere to the I/R region, consequently inducing multiorgan injury. Emerging data indicate that upon I/R, stress‑inducible proteins, including activating transcription factor 3 (ATF3), play essential roles in signaling during antiapoptotic, antimigration, and anti‑inflammatory processes. Accumulating data suggest that ATF3 may be a potential target in I/R‑ or inflammation‑induced organ dysfunction. This minireview focuses on the emerging evidence of the roles of ATF3 in multiple organs including the kidney, myocardium, and brain following I/R injury. In addition, this review addresses the role of ATF3 in chronic inflammation‑induced pathophysiologies such as diabetes and atherosclerosis.


Keywords: Activating transcription factor 3, Ischemia, Reperfusion

On the Cover

Search all Issue